RosaKimMD

Ophthalmology • Houston, TX

Retinal Disease, Uveitis

Partner, Retina Consultants of Houston; Clinical Assistant Professor, Cornell-Weill Medical Center

Join to view full profile

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

Office
6560 Fannin St
Ste 750
Houston, TX 77030
Phone+1 713-524-3434

Fax+1 713-524-3220

Education & Training

Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1995 - 1998
Mount Auburn HospitalInternship, Internal Medicine, 1993 - 1994
Stanford University School of MedicineClass of 1993

Certifications & Licensure

TX State Medical License 2000 - 2025
LA State Medical License 2000 - 2007
MA State Medical License 1998 - 2003
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion Start of enrollment: 2012 Oct 01
Completed
Phase 4
A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema Start of enrollment: 2013 Nov 01
Completed
Phase 1, Phase 2
Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy. Start of enrollment: 2014 Sep 23
Completed
Phase 2

Publications & Presentations

PubMed

Macular Edema Ranibizumab v. Intravitreal anti-inflammatory Therapy (MERIT) Trial-24-week Outcomes of Uveitic Macular Edema Retreatment.
, John Gonzales, Nisha R Acharya, Elizabeth A Sugar, Alyce E Burke
Ophthalmology. 2024-11-27
MANAGEMENT OF LARGE FULL-THICKNESS MACULAR HOLES: Long-Term Outcomes of Internal Limiting Membrane Flaps and Internal Limiting Membrane Peels.
Kaitlyn Richards, Ankit Kadakia, Charles C Wykoff, James C Major Jr, Tien P Wong
Retina. 2024-07-01
42 citations
Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial.
David M. Brown, William C. Ou, Tien P. Wong, Rosa Y. Kim, Daniel E. Croft
Ophthalmology. 2018-05-01

Press Mentions

Chutes & Ladders—Vertex Appoints BMS Vet Atkinson to Head ManufacturingJuly 17th, 2020
DAVE Study Found Little Benefit of anti-VEGF/PRP for DMEApril 12th, 2017

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow